LaBonne is president of the Society for Developmental Biology and the Erastus Otis Haven professor of molecular biosciences at Northwestern University. Imagine a world without lifesaving medicines, ...

Before the FDA Modernization Act 2.0 was passed in December 2022, the US government required that all investigational drugs be tested on animals before they could advance to human trials. Although ...

Ten years ago, CRISPR gene editing was introduced to the world by a paper in Science. Just eight years later, the paper’s senior authors, Jennifer A. Doudna and Emmanuelle Charpentier, shared the ...

Every year, more than 100 million animals are used globally in biomedical research, yet over 90% of drugs that appear effective in animal trials fail during human clinical testing. 1 This staggering ...

In recent months, the Food and Drug Administration and National Institutes of Health have announced new initiatives to reduce and replace animal testing in biomedical research. Central to these ...

A fundamental challenge in preclinical research is accurately predicting human responses using conventional animal models. Traditional approaches often fail to adequately model human disease, creating ...

This chapter examines how well specific animal models against biothreats of interest to the Transformational Medical Technologies (TMT) reflect various aspects of the human diseases for which medical ...